Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders

Hepcidin, a hormone regulating iron metabolism, has received attention for its role in the pathogenesis of dysregulations in carbohydrate metabolism. Hepcidin disorders in patients with diabetes mellitus are bi-directional: manifesting as iron overload syndrome in cases of decreased hepcidin product...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatiana V. Saprina, Anastasia P. Zima, Nadezhda N. Musina, Tatiana S. Prokhorenko, Alina V. Latypova, Natalia S. Shakhmanova, Svetlana V. Budeeva
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2018
Materias:
Acceso en línea:https://doaj.org/article/92cf2e1e55844409b21568bef874c7ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:92cf2e1e55844409b21568bef874c7ff
record_format dspace
spelling oai:doaj.org-article:92cf2e1e55844409b21568bef874c7ff2021-11-14T09:00:22ZPathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders2072-03512072-037810.14341/DM9378https://doaj.org/article/92cf2e1e55844409b21568bef874c7ff2018-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9378https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Hepcidin, a hormone regulating iron metabolism, has received attention for its role in the pathogenesis of dysregulations in carbohydrate metabolism. Hepcidin disorders in patients with diabetes mellitus are bi-directional: manifesting as iron overload syndrome in cases of decreased hepcidin production and as anaemia of chronic disease in cases of hepcidin hypersecretion. However, till date, detailed analyses of mechanisms underlying hepcidin dysregulation have not been conducted nor have the interactions of ferrocinetic and carbohydrate-metabolic disorders been examined. An association between diabetes mellitus and neurodegenerative diseases as well as the role of iron metabolism in Alzheimer or Parkinson diseases is a subject of ongoing research. This review provides a summary of the current understanding of hepcidin regulation and its disorders in various diseases, including diabetes mellitus and neurodegenerative diseases. In addition, we provide an overview of the available therapies that address ferrocinetic disorders resulting from the dysregulation of hepcidin.Tatiana V. SaprinaAnastasia P. ZimaNadezhda N. MusinaTatiana S. ProkhorenkoAlina V. LatypovaNatalia S. ShakhmanovaSvetlana V. BudeevaEndocrinology Research Centrearticlediabetes mellitushepcidinanemia of chronic diseaseiron overloadalzheimer diseaseparkinson diseaseNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 6, Pp 506-512 (2018)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus
hepcidin
anemia of chronic disease
iron overload
alzheimer disease
parkinson disease
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus
hepcidin
anemia of chronic disease
iron overload
alzheimer disease
parkinson disease
Nutritional diseases. Deficiency diseases
RC620-627
Tatiana V. Saprina
Anastasia P. Zima
Nadezhda N. Musina
Tatiana S. Prokhorenko
Alina V. Latypova
Natalia S. Shakhmanova
Svetlana V. Budeeva
Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
description Hepcidin, a hormone regulating iron metabolism, has received attention for its role in the pathogenesis of dysregulations in carbohydrate metabolism. Hepcidin disorders in patients with diabetes mellitus are bi-directional: manifesting as iron overload syndrome in cases of decreased hepcidin production and as anaemia of chronic disease in cases of hepcidin hypersecretion. However, till date, detailed analyses of mechanisms underlying hepcidin dysregulation have not been conducted nor have the interactions of ferrocinetic and carbohydrate-metabolic disorders been examined. An association between diabetes mellitus and neurodegenerative diseases as well as the role of iron metabolism in Alzheimer or Parkinson diseases is a subject of ongoing research. This review provides a summary of the current understanding of hepcidin regulation and its disorders in various diseases, including diabetes mellitus and neurodegenerative diseases. In addition, we provide an overview of the available therapies that address ferrocinetic disorders resulting from the dysregulation of hepcidin.
format article
author Tatiana V. Saprina
Anastasia P. Zima
Nadezhda N. Musina
Tatiana S. Prokhorenko
Alina V. Latypova
Natalia S. Shakhmanova
Svetlana V. Budeeva
author_facet Tatiana V. Saprina
Anastasia P. Zima
Nadezhda N. Musina
Tatiana S. Prokhorenko
Alina V. Latypova
Natalia S. Shakhmanova
Svetlana V. Budeeva
author_sort Tatiana V. Saprina
title Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
title_short Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
title_full Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
title_fullStr Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
title_full_unstemmed Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
title_sort pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
publisher Endocrinology Research Centre
publishDate 2018
url https://doaj.org/article/92cf2e1e55844409b21568bef874c7ff
work_keys_str_mv AT tatianavsaprina pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
AT anastasiapzima pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
AT nadezhdanmusina pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
AT tatianasprokhorenko pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
AT alinavlatypova pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
AT nataliasshakhmanova pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
AT svetlanavbudeeva pathogeneticaspectsofhepcidinmetabolismandferrocineticsdysregulationincarbohydratemetabolismdisorders
_version_ 1718429476285579264